Merck KGaA (OTCMKTS:MKKGY), headquartered in Darmstadt, Germany, is a leading science and technology company with a heritage dating back to 1668. Over its more than three centuries of history, the company has evolved from a family-run apothecary into a global enterprise operating in the healthcare, life science and electronics sectors. Merck KGaA distinguishes itself by integrating chemistry, biotechnology and advanced materials to develop innovative solutions across a variety of industries.
In its Healthcare division, Merck KGaA focuses on prescription pharmaceuticals in areas such as oncology, immuno-oncology, neurology, fertility and endocrinology. The company’s portfolio includes targeted therapies, biologics and small-molecule drugs designed to address critical unmet medical needs. Through a robust pipeline and strategic collaborations, the division aims to advance novel treatments from early research to clinical application.
The Life Science arm serves academic research, biotech and pharmaceutical customers with an extensive range of products and services. These include lab reagents, cell culture media, instruments for analytical and preparative processes, and custom services for process development and manufacturing of biologics. By offering end-to-end solutions, Merck KGaA supports innovation throughout the drug discovery and production lifecycle.
Merck KGaA’s Electronics division supplies specialty materials for the semiconductor and display industries, including photoresists, high-purity chemicals and liquid crystals for flat-panel displays. With operations in over 60 countries, the company leverages its global footprint to meet regional market needs. Under the leadership of Chief Executive Officer Belén Garijo, Merck KGaA continues to invest in research and development, aiming to drive sustainable growth and address challenges in health, science and technology worldwide.
